The Purinosome: A Case Study for a Mammalian Metabolon

Literature Cited

1. 1.

   Nyhan WL. 2014. Nucleotide synthesis via salvage pathway. eLS San Francisco: John Wiley and Sons Ltd.
   [Google Scholar]
2. 2.

   Yin J, Ren W, Huang X, Deng J, Li T, Yin Y. 2018. Potential mechanisms connecting purine metabolism and cancer therapy. Front. Immunol. 9:1697
   [Google Scholar]
3. 3.

   Ashihara H, Ludwig IA, Crozier A 2020. Salvage pathways of purine nucleotide biosynthesis. Plant Nucleotide Metabolism—Biosynthesis, Degradation, and Alkaloid Formation H Ashihara, IA Ludwig, A Crozier 55–69 Hoboken, NJ: John Wiley & Sons Ltd.
   [Google Scholar]
4. 4.

   Pareek V, Pedley AM, Benkovic SJ. 2021. Human de novo purine biosynthesis. Crit. Rev. Biochem. Mol. Biol. 56:1–16
   [Google Scholar]
5. 5.

   Henderson JF, Khoo KY. 1965. On the mechanism of feedback inhibition of purine biosynthesis de novo in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 240:3104–9
   [Google Scholar]
6. 6.

   Lane AN, Fan TW. 2015. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res 43:2466–85
   [Google Scholar]
7. 7.

   Murray AW. 1971. The biological significance of purine salvage. Annu. Rev. Biochem. 40:811–26
   [Google Scholar]
8. 8.

   Yamaoka T, Kondo M, Honda S, Iwahana H, Moritani M et al. 1997. Amidophosphoribosyltransferase limits the rate of cell growth-linked de novo purine biosynthesis in the presence of constant capacity of salvage purine biosynthesis. J. Biol. Chem. 272:17719–25
   [Google Scholar]
9. 9.

   Villa E, Ali ES, Sahu U, Ben-Sahra I. 2019. Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides. Cancers 11:688
   [Google Scholar]
10. 10.

    Fu R, Sutcliffe D, Zhao H, Huang X, Schretlen DJ et al. 2015. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways. Mol. Genet. Metab. 114:55–61
    [Google Scholar]
11. 11.

    Zoref E, Sperling O. 1979. Increased de novo purine synthesis in cultured skin fibroblasts from heterozygotes for the Lesch-Nyhan syndrome: a sensitive marker for carrier detection. Hum. Hered 29:64–68
    [Google Scholar]
12. 12.

    Fridman A, Saha A, Chan A, Casteel DE, Pilz RB, Boss GR. 2013. Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate. Biochem. J. 454:91–99
    [Google Scholar]
13. 13.

    Zalkin H, Dixon JE. 1992. De novo purine nucleotide biosynthesis. Prog. Nucleic Acid Res. Mol. Biol. 42:259–87
    [Google Scholar]
14. 14.

    Hove-Jensen B, Andersen KR, Kilstrup M, Martinussen J, Switzer RL, Willemoës M. 2017. Phosphoribosyl diphosphate (PRPP): biosynthesis, enzymology, utilization, and metabolic significance. Microbiol. Mol. Biol. Rev. 81:e00040–16
    [Google Scholar]
15. 15.

    An S, Kumar R, Sheets ED, Benkovic SJ. 2008. Reversible compartmentalization of de novo purine biosynthetic complexes in living cells. Science 320:103–6
    [Google Scholar]
16. 16.

    Schmitt DL, Sundaram A, Jeon M, Luu BT, An S 2018. Spatial alterations of de novo purine biosynthetic enzymes by Akt-independent PDK1 signaling pathways. PLOS ONE 13:e0195989
    [Google Scholar]
17. 17.

    Doigneaux C, Pedley AM, Mistry IN, Papayova M, Benkovic SJ, Tavassoli A. 2020. Hypoxia drives the assembly of the multienzyme purinosome complex. J. Biol. Chem. 295:9551–66
    [Google Scholar]
18. 18.

    French JB, Zhao H, An S, Niessen S, Deng Y et al. 2013. Hsp70/Hsp90 chaperone machinery is involved in the assembly of the purinosome. PNAS 110:2528–33
    [Google Scholar]
19. 19.

    Baresova V, Skopova V, Sikora J, Patterson D, Sovova J et al. 2012. Mutations of ATIC and ADSL affect purinosome assembly in cultured skin fibroblasts from patients with AICA-ribosiduria and ADSL deficiency. Hum. Mol. Genet. 21:1534–43
    [Google Scholar]
20. 20.

    Mangold CA, Yao PJ, Du M, Freeman WM, Benkovic SJ, Szpara ML. 2018. Expression of the purine biosynthetic enzyme phosphoribosyl formylglycinamidine synthase in neurons. J. Neurochem. 144:723–35
    [Google Scholar]
21. 21.

    Yamada S, Sato A, Sakakibara SI. 2020. Nwd1 regulates neuronal differentiation and migration through purinosome formation in the developing cerebral cortex. iScience 23:101058
    [Google Scholar]
22. 22.

    Williamson J, Petralia RS, Wang YX, Mattson MP, Yao PJ. 2017. Purine biosynthesis enzymes in hippocampal neurons. Neuromol. Med. 19:518–24
    [Google Scholar]
23. 23.

    Chan CY, Pedley AM, Kim D, Xia C, Zhuang X, Benkovic SJ. 2018. Microtubule-directed transport of purine metabolons drives their cytosolic transit to mitochondria. PNAS 115:13009–14
    [Google Scholar]
24. 24.

    Zhao A, Tsechansky M, Ellington AD, Marcotte EM. 2014. Revisiting and revising the purinosome. Mol. Biosyst. 10:369–74
    [Google Scholar]
25. 25.

    Zhao A, Tsechansky M, Swaminathan J, Cook L, Ellington AD, Marcotte EM. 2013. Transiently transfected purine biosynthetic enzymes form stress bodies. PLOS ONE 8:e56203
    [Google Scholar]
26. 26.

    Narayanaswamy R, Levy M, Tsechansky M, Stovall GM, O'Connell JD et al. 2009. Widespread reorganization of metabolic enzymes into reversible assemblies upon nutrient starvation. PNAS 106:10147–52
    [Google Scholar]
27. 27.

    Chan CY, Zhao H, Pugh RJ, Pedley AM, French J et al. 2015. Purinosome formation as a function of the cell cycle. PNAS 112:1368–73
    [Google Scholar]
28. 28.

    French JB, Jones SA, Deng H, Pedley AM, Kim D et al. 2016. Spatial colocalization and functional link of purinosomes with mitochondria. Science 351:733–37
    [Google Scholar]
29. 29.

    Pedley AM, Boylan JP, Chan CY, Kennedy EL, Kyoung M, Benkovic SJ. 2022. Purine biosynthetic enzymes assemble into liquid-like condensates dependent on the activity of chaperone protein HSP90. J. Biol. Chem. 298:101845
    [Google Scholar]
30. 30.

    Kyoung M, Russell SJ, Kohnhorst CL, Esemoto NN, An S 2015. Dynamic architecture of the purinosome involved in human de novo purine biosynthesis. Biochemistry 54:870–80
    [Google Scholar]
31. 31.

    Baresova V, Krijt M, Skopova V, Souckova O, Kmoch S, Zikanova M. 2016. CRISPR-Cas9 induced mutations along de novo purine synthesis in HeLa cells result in accumulation of individual enzyme substrates and affect purinosome formation. Mol. Genet. Metab. 119:270–77
    [Google Scholar]
32. 32.

    Baresova V, Skopova V, Souckova O, Krijt M, Kmoch S, Zikanova M. 2018. Study of purinosome assembly in cell-based model systems with de novo purine synthesis and salvage pathway deficiencies. PLOS ONE 13:e0201432
    [Google Scholar]
33. 33.

    Pareek V, Tian H, Winograd N, Benkovic SJ. 2020. Metabolomics and mass spectrometry imaging reveal channeled de novo purine synthesis in cells. Science 368:283–90
    [Google Scholar]
34. 34.

    Zhao H, Chiaro CR, Zhang L, Smith PB, Chan CY et al. 2015. Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis. J. Biol. Chem. 290:6705–13
    [Google Scholar]
35. 35.

    He J, Zou L-N, Pareek V, Benkovic SJ. 2022. Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling. J. Biol. Chem. 298:101853
    [Google Scholar]
36. 36.

    Wan C, Borgeson B, Phanse S, Tu F, Drew K et al. 2015. Panorama of ancient metazoan macromolecular complexes. Nature 525:339–44
    [Google Scholar]
37. 37.

    An S, Deng Y, Tomsho JW, Kyoung M, Benkovic SJ. 2010. Microtubule-assisted mechanism for functional metabolic macromolecular complex formation. PNAS 107:12872–76
    [Google Scholar]
38. 38.

    Rudolph J, Stubbe J. 1995. Investigation of the mechanism of phosphoribosylamine transfer from glutamine phosphoribosylpyrophosphate amidotransferase to glycinamide ribonucleotide synthetase. Biochemistry 34:2241–50
    [Google Scholar]
39. 39.

    Mazzarino RC, Baresova V, Zikanova M, Duval N, Wilkinson TG 2nd et al. 2021. Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: alterations in CD36 expression and activity. PLOS ONE 16:e0247227
    [Google Scholar]
40. 40.

    Pedley AM, Benkovic SJ. 2017. A new view into the regulation of purine metabolism: the purinosome. Trends Biochem. Sci. 42:141–54
    [Google Scholar]
41. 41.

    Bulock KG, Beardsley GP, Anderson KS. 2002. The kinetic mechanism of the human bifunctional enzyme ATIC (5-amino-4-imidazolecarboxamide ribonucleotide transformylase/inosine 5′-monophosphate cyclohydrolase). A surprising lack of substrate channeling. J. Biol. Chem. 277:22168–74
    [Google Scholar]
42. 42.

    Pareek V, Sha Z, He J, Wingreen NS, Benkovic SJ. 2021. Metabolic channeling: predictions, deductions, and evidence. Mol. Cell 81:3775–85
    [Google Scholar]
43. 43.

    Diehl FF, Lewis CA, Fiske BP, Vander Heiden MG 2019. Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation. Nat. Metab. 1:861–67
    [Google Scholar]
44. 44.

    Tibbetts AS, Appling DR. 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30:57–81
    [Google Scholar]
45. 45.

    Ducker GS, Rabinowitz JD. 2017. One-carbon metabolism in health and disease. Cell Metab 25:27–42
    [Google Scholar]
46. 46.

    Newman AC, Maddocks ODK. 2017. One-carbon metabolism in cancer. Br. J. Cancer 116:1499–504
    [Google Scholar]
47. 47.

    Verrier F, An S, Ferrie AM, Sun H, Kyoung M et al. 2011. GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis. Nat. Chem. Biol. 7:909–15
    [Google Scholar]
48. 48.

    Fang Y, French J, Zhao H, Benkovic S. 2013. G-protein-coupled receptor regulation of de novo purine biosynthesis: a novel druggable mechanism. Biotechnol. Genet. Eng. Rev. 29:31–48
    [Google Scholar]
49. 49.

    Fang Y. 2014. Label-free drug discovery. Front. Pharmacol. 5:52
    [Google Scholar]
50. 50.

    Fang Y. 2014. Label-free cell phenotypic drug discovery. Comb. Chem. High Throughput Screen. 17:566–78
    [Google Scholar]
51. 51.

    Ferrie AM, Goral V, Wang C, Fang Y. 2015. Label-free functional selectivity assays. Methods Mol. Biol. 1272:227–46
    [Google Scholar]
52. 52.

    Zhang W, Liu HT. 2002. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18
    [Google Scholar]
53. 53.

    Ali ES, Sahu U, Villa E, O'Hara BP, Gao P et al. 2020. ERK2 phosphorylates PFAS to mediate posttranslational control of de novo purine synthesis. Mol. Cell 78:1178–91.e6
    [Google Scholar]
54. 54.

    Ben-Sahra I, Hoxhaj G, Ricoult SJH, Asara JM, Manning BD. 2016. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science 351:728–33
    [Google Scholar]
55. 55.

    Liu C, Knudsen GM, Pedley AM, He J, Johnson JL et al. 2019. Mapping post-translational modifications of de novo purine biosynthetic enzymes: implications for pathway regulation. J. Proteome Res. 18:2078–87
    [Google Scholar]
56. 56.

    Pedley AM, Karras GI, Zhang X, Lindquist S, Benkovic SJ. 2018. Role of HSP90 in the regulation of de novo purine biosynthesis. Biochemistry 57:3217–21
    [Google Scholar]
57. 57.

    Calvo-Vidal MN, Zamponi N, Krumsiek J, Stockslager MA, Revuelta MV et al. 2021. Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas. Cancer Res 81:5202–16
    [Google Scholar]
58. 58.

    Bassard JE, Halkier BA. 2018. How to prove the existence of metabolons?. Phytochem. Rev. 17:211–27
    [Google Scholar]
59. 59.

    Reed LJ. 1974. Multienzyme complexes. Acc. Chem. Res. 7:40–46
    [Google Scholar]
60. 60.

    McConkey EH. 1982. Molecular evolution, intracellular organization, and the quinary structure of proteins. PNAS 79:3236–40
    [Google Scholar]
61. 61.

    Wilson JE. 1978. Ambiquitous enzymes: variation in intracellular distribution as a regulatory mechanism. Trends Biochem. Sci. 3:124–25
    [Google Scholar]
62. 62.

    Srere PA. 1985. The metabolon. Trends Biochem. Sci. 10:109–10
    [Google Scholar]
63. 63.

    Srere PA. 1987. Complexes of sequential metabolic enzymes. Annu. Rev. Biochem. 56:89–124
    [Google Scholar]
64. 64.

    Pedley AM, Benkovic SJ. 2018. Detecting purinosome metabolon formation with fluorescence microscopy. Methods Mol. Biol. 1764:279–89
    [Google Scholar]
65. 65.

    Lu A, Disoma C, Zhou Y, Chen Z, Zhang Let al 2019. Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS. Biochem. Biophys. Res. Commun 513:746–52
    [Google Scholar]
66. 66.

    Huang X, Holden HM, Raushel FM 2001. Channeling of substrates and intermediates in enzyme-catalyzed reactions. Annu. Rev. Biochem 70:149–80
    [Google Scholar]